Figure 2
Secretion of IL-12 by CAR-modified T cells may improve cytotoxicity of CAR + T cells and reverse anergy in tumor infiltrating lymphocytes.
Figure 2 | Journal of Translational Medicine
Secretion of IL-12 by CAR-modified T cells may improve cytotoxicity of CAR + T cells and reverse anergy in tumor infiltrating lymphocytes.